Sign In to Follow Application
View All Documents & Correspondence

A Single Step Process For The Preparation Of 2 Cyano N,N Diethyl Acetamide Intermediate Useful In Preparation Of Entacapone

Abstract: The present invention provides a process for the preparation of 2-cyano-N,N-diethylacetamide intermediate useful in preparation of Entacapone, wherein the said process comprises of a) reacting N,N-diethyl amine with cyano acetic acid in presence of dicyclohexylcarbodiimide using organic solvent, b) isolating the 2-cyano-N,N-diethylacetamide from reaction mass thereof.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
30 October 2006
Publication Number
33/2008
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2014-12-09
Renewal Date

Applicants

WOCKHARDT LTD
WOCKHARDT TOWERS, BANDRA-KURLA COMPLEX, BANDRA(EAST), MUMBAI-400 051,

Inventors

1. YADAV RAM PRASAD
VILLAGE : LAKHANPUR, POST MAWAIYA, DIST. MIRZAPUR- 231001,
2. SHAIKH ZAKIR GAFOOR
Village & Post - Warigaon, Tehsil-Kopargaon, Dist.Ahmednagar- 413708
3. SIDDIQUI MOHAMMED JAWEED MUKARRAM
H.No. 4-8-65, Nawabpura, Near Nagina Masjid, Aurangabad -431 001

Specification

FORM 2
THE PATENT ACT 1970
(39 of 1970)
&
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See section 10 and rule13)
1. TITLE OF THE INVENTION:
A SINGLE STEP PROCESS FOR THE PREPARATION OF 2-CYANO- N, N-
DIETHYL ACETAMIDE INTERMEDIATE USEFUL IN PREPARATION OF
ENTACAPONE.
2. APPLICANT (S)
(a) NAME: WOCKHARDT LTD.
(b) NATIONALITY: INDIAN
(c) ADDRESS: Wockhardt Towers, Bandra-Kurla Complex, Bandra
(East), Mumbai- 400 051.
3. PREAMBLE TO THE DESCRIPTION
The present invention provides a single step process for the preparation of 2-
cyano-N,N-diethyl acetamide intermediate useful in preparation of
entacapone
The following specification particularly describes the invention and the manner
in which it is to be performed.
1

4. DESCRIPTION
The present invention provides a single step process for the preparation of 2-cyano-N,N-diethylacetamide, an intermediate useful in preparation of entacapone.
Entacapone of formula I is chemically known as (E)-N, N-Diethyl-2- cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide.


rHM /CH2CH3 i ,C-N;
C=C^ C H jC Hg CN

Formula I
British patent No. 8,727,854 describes entacapone as a potent inhibitor of catechol-O-methyl- transferase (COMT) enzyme. The product is indicated for the treatment of Parkinson's disease.
US Patent 4,963,590 discloses a process for the preparation of entacapone (Formula I) by the condensation of 3,4-Dihydroxy-5- nitrobenzaldehyde and N, N-diethylcyanoacetamide in anhydrous ethanol.
US Patent 5,135,950 discloses crystallographically essentially pure and stable polymorphic form A of entacapone.
The processes of preparation of entacapone and different polymorphic forms are also disclosed in PCT application WO 2005063693; WO 2005063695; WO 2005063696; WO 2005066117 and WO 2005070881.
German patent DE 2538254 disclosed the process of preparation of 2-cyano-N, N-diethylacetamide by reacting halo-acetamide derivatives with alkali cyanide in the presence of water as a solvent.
2

Present invention provides an easy single step process for the preparation of 2-cyano-N,N-diethylacetamide intermediate useful in preparation of entacapone without use of toxic and lachrymatory alkali cyanide, chloroacetyl chloride reagents and haloacetamide.
In the aspect of present invention there is provided a process for the preparation of 2-cyano-N,N-diethylacetamide intermediate useful in preparation of Entacapone, wherein the said process comprises of
a) reacting N,N-diethyl amine with cyano acetic acid in presence of dicyclohexylcarbodiimide,
b) isolating the 2-cyano-N,N-diethylacetamide from reaction mass thereof,
The compound obtained from step b) is condensed with 3, 4-dihydroxy-5-nitrobenzaldehyde to get entacapone as method known in the art.
The process involves reacting N,N-diethyl amine with cyano acetic acid using organic solvent in presence of dicyclohexylcarbodiimide at reflux temperature. After completion of reaction, the reaction mixture was concentrated and residue is treated with mixture of water and acetic acid. The dicyclohexyl urea was filtered and the product was extracted with organic solvent. The organic solvent was concentrated and 2-cyano-N,N-diethylacetamide isolated from the reaction mass thereof.
The non-limiting examples of organic solvents include haloalkanes, ethers, and aromatic solvents. Haloalkanes such as methylene chloride, chloroform, carbon tetrachloride and the like or ethers such as diethyl ether, tetrahydrofuran, dioxane and the like or aromatic solvents such as toluene, xylene and the like. While the present invention has been described in terms of its specific embodiments, certain modifications and equivalents will be apparent to those skilled in the art and are intended to be included within the scope of the present invention.
3

EXAMPLE
Preparation of 2-Cyano-N, N-Diethyl acetamide
Charged tetrahydrofuran (235 Litre) followed by dicyclohexylcarbodiimide (85 Kg), N,N-diethyl amine (34 Kg) and cyano acetic acid (36 Kg). Reflux the reaction mixture for 6-9 hour. After completion of reaction, reaction mixture was concentrated and residue treated with mixture of water (275 Litre) and acetic acid (12 Litre). Undissolved dicylohexylurea was removed through Alteration and filtrate was extracted with dichloromethane. Dichloromethane layer was concentrated to get the 2-Cyano-N,N-Diethyl acetamide as oil. Yield: 55.2 Kg.
4

WE CLAIM:
1. A process for the preparation of 2-cyano-N,N-diethylacetamide
intermediate useful in preparation of Entacapone, wherein the said
process comprises of
a) reacting N,N-diethyl amine with cyano acetic acid in presence of dicyclohexylcarbodiimide using organic solvent,
b) isolating the 2-cyano-N,N-diethylacetamide from reaction mass thereof.

2. A compound obtained according to claim 1 used in the synthesis of entacapone.
3. A process of claim 1 wherein the organic solvent is tetrahydrofuran.
4. Use of intermediate prepared according to process of claim 1 for the preparation of entacapone.

Dated this 30th day of October, 2006

For Wockhardt Limited


5

(Mandar Kodgule) Authorized Signatory

Documents

Application Documents

# Name Date
1 1792-mum-2006-claim.pdf 2018-08-09
1 1792-MUM-2006-FORM 2(TITLE PAGE)-(30-10-2006).pdf 2006-10-30
2 1792-MUM-2006-FORM 18(19-10-2010).pdf 2010-10-19
2 1792-MUM-2006-CLAIMS(GRANTED)-(9-12-2014)..pdf 2018-08-09
3 1792-MUM-2006-REPLY TO EXAMINATION REPORT(27-12-2013).pdf 2013-12-27
4 1792-mum-2006-correspondance-received.pdf 2018-08-09
4 1792-MUM-2006-CLAIMS(MARKED COPY)-(27-12-2013).pdf 2013-12-27
5 1792-MUM-2006-CORRESPONDENCE(IPO)-(9-12-2014).pdf 2018-08-09
5 1792-MUM-2006-CLAIMS(AMENDED)-(27-12-2013).pdf 2013-12-27
6 1792-MUM-2006-FORM 13--(31-03-2016).pdf 2016-03-31
6 1792-mum-2006-description (complete).pdf 2018-08-09
7 1792-MUM-2006-FORM 13-(31-03-2016).pdf 2016-03-31
7 1792-MUM-2006-DISCRIPTION(GRANTED)-(9-12-2014)..pdf 2018-08-09
8 1792-MUM-2006-FORM 2(TITLE PAGE)-(GRANTED)-(9-12-2014).pdf 2018-08-09
8 1792-MUM-2006-CORRESPONDENCE-(31-03-2016).pdf 2016-03-31
9 Form 27 [28-03-2017(online)].pdf 2017-03-28
9 1792-MUM-2006-FORM FORM 2(GRANTED)-(9-12-2014)..pdf 2018-08-09
10 1792-mum-2006-form-1.pdf 2018-08-09
10 1792-MUM-2006_EXAMREPORT.pdf 2018-08-09
11 1792-mum-2006-form-2.pdf 2018-08-09
12 1792-mum-2006-form-2.pdf 2018-08-09
13 1792-mum-2006-form-1.pdf 2018-08-09
13 1792-MUM-2006_EXAMREPORT.pdf 2018-08-09
14 1792-MUM-2006-FORM FORM 2(GRANTED)-(9-12-2014)..pdf 2018-08-09
14 Form 27 [28-03-2017(online)].pdf 2017-03-28
15 1792-MUM-2006-CORRESPONDENCE-(31-03-2016).pdf 2016-03-31
15 1792-MUM-2006-FORM 2(TITLE PAGE)-(GRANTED)-(9-12-2014).pdf 2018-08-09
16 1792-MUM-2006-DISCRIPTION(GRANTED)-(9-12-2014)..pdf 2018-08-09
16 1792-MUM-2006-FORM 13-(31-03-2016).pdf 2016-03-31
17 1792-mum-2006-description (complete).pdf 2018-08-09
17 1792-MUM-2006-FORM 13--(31-03-2016).pdf 2016-03-31
18 1792-MUM-2006-CLAIMS(AMENDED)-(27-12-2013).pdf 2013-12-27
18 1792-MUM-2006-CORRESPONDENCE(IPO)-(9-12-2014).pdf 2018-08-09
19 1792-MUM-2006-CLAIMS(MARKED COPY)-(27-12-2013).pdf 2013-12-27
19 1792-mum-2006-correspondance-received.pdf 2018-08-09
20 1792-MUM-2006-REPLY TO EXAMINATION REPORT(27-12-2013).pdf 2013-12-27
21 1792-MUM-2006-FORM 18(19-10-2010).pdf 2010-10-19
21 1792-MUM-2006-CLAIMS(GRANTED)-(9-12-2014)..pdf 2018-08-09
22 1792-MUM-2006-FORM 2(TITLE PAGE)-(30-10-2006).pdf 2006-10-30
22 1792-mum-2006-claim.pdf 2018-08-09

ERegister / Renewals

3rd: 07 Jan 2015

From 30/10/2008 - To 30/10/2009

4th: 07 Jan 2015

From 30/10/2009 - To 30/10/2010

5th: 07 Jan 2015

From 30/10/2010 - To 30/10/2011

6th: 07 Jan 2015

From 30/10/2011 - To 30/10/2012

7th: 07 Jan 2015

From 30/10/2012 - To 30/10/2013

8th: 07 Jan 2015

From 30/10/2013 - To 30/10/2014

9th: 07 Jan 2015

From 30/10/2014 - To 30/10/2015

10th: 07 Jan 2015

From 30/10/2015 - To 30/10/2016

11th: 14 Oct 2016

From 30/10/2016 - To 30/10/2017